Nuclear volume and prognosis in ovarian cancer
The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Mogensen, O. [verfasserIn] Sørensen, F.B. [verfasserIn] Bichel, P. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA: Blackwell Scientific Publications ; 1992 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2002 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: International journal of gynecological cancer - Oxford [u.a.] : Wiley-Blackwell, 1991, 2(1992), 3, Seite 0 |
| Übergeordnetes Werk: |
volume:2 ; year:1992 ; number:3 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1046/j.1525-1438.1992.02030141.x |
|---|
| Katalog-ID: |
NLEJ239411528 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ239411528 | ||
| 003 | DE-627 | ||
| 005 | 20230506180143.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120426s1992 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1046/j.1525-1438.1992.02030141.x |2 doi | |
| 035 | |a (DE-627)NLEJ239411528 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Mogensen, O. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nuclear volume and prognosis in ovarian cancer |
| 264 | 1 | |a Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA |b Blackwell Scientific Publications |c 1992 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. | ||
| 533 | |d 2002 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2002|||||||||| | ||
| 650 | 4 | |a morphometry | |
| 700 | 1 | |a Sørensen, F.B. |e verfasserin |4 aut | |
| 700 | 1 | |a Bichel, P. |e verfasserin |4 aut | |
| 700 | 1 | |a Jakobsen, A. |4 oth | |
| 773 | 0 | 8 | |i In |t International journal of gynecological cancer |d Oxford [u.a.] : Wiley-Blackwell, 1991 |g 2(1992), 3, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243926197 |w (DE-600)2009072-9 |x 1525-1438 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:1992 |g number:3 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 1992 |e 3 |h 0 | ||
| author_variant |
o m om f s fs p b pb |
|---|---|
| matchkey_str |
article:15251438:1992----::ulavlmadrgoiioa |
| hierarchy_sort_str |
1992 |
| publishDate |
1992 |
| allfields |
10.1046/j.1525-1438.1992.02030141.x doi (DE-627)NLEJ239411528 DE-627 ger DE-627 rakwb Mogensen, O. verfasserin aut Nuclear volume and prognosis in ovarian cancer Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA Blackwell Scientific Publications 1992 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| morphometry Sørensen, F.B. verfasserin aut Bichel, P. verfasserin aut Jakobsen, A. oth In International journal of gynecological cancer Oxford [u.a.] : Wiley-Blackwell, 1991 2(1992), 3, Seite 0 Online-Ressource (DE-627)NLEJ243926197 (DE-600)2009072-9 1525-1438 nnns volume:2 year:1992 number:3 pages:0 http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 2 1992 3 0 |
| spelling |
10.1046/j.1525-1438.1992.02030141.x doi (DE-627)NLEJ239411528 DE-627 ger DE-627 rakwb Mogensen, O. verfasserin aut Nuclear volume and prognosis in ovarian cancer Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA Blackwell Scientific Publications 1992 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| morphometry Sørensen, F.B. verfasserin aut Bichel, P. verfasserin aut Jakobsen, A. oth In International journal of gynecological cancer Oxford [u.a.] : Wiley-Blackwell, 1991 2(1992), 3, Seite 0 Online-Ressource (DE-627)NLEJ243926197 (DE-600)2009072-9 1525-1438 nnns volume:2 year:1992 number:3 pages:0 http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 2 1992 3 0 |
| allfields_unstemmed |
10.1046/j.1525-1438.1992.02030141.x doi (DE-627)NLEJ239411528 DE-627 ger DE-627 rakwb Mogensen, O. verfasserin aut Nuclear volume and prognosis in ovarian cancer Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA Blackwell Scientific Publications 1992 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| morphometry Sørensen, F.B. verfasserin aut Bichel, P. verfasserin aut Jakobsen, A. oth In International journal of gynecological cancer Oxford [u.a.] : Wiley-Blackwell, 1991 2(1992), 3, Seite 0 Online-Ressource (DE-627)NLEJ243926197 (DE-600)2009072-9 1525-1438 nnns volume:2 year:1992 number:3 pages:0 http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 2 1992 3 0 |
| allfieldsGer |
10.1046/j.1525-1438.1992.02030141.x doi (DE-627)NLEJ239411528 DE-627 ger DE-627 rakwb Mogensen, O. verfasserin aut Nuclear volume and prognosis in ovarian cancer Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA Blackwell Scientific Publications 1992 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| morphometry Sørensen, F.B. verfasserin aut Bichel, P. verfasserin aut Jakobsen, A. oth In International journal of gynecological cancer Oxford [u.a.] : Wiley-Blackwell, 1991 2(1992), 3, Seite 0 Online-Ressource (DE-627)NLEJ243926197 (DE-600)2009072-9 1525-1438 nnns volume:2 year:1992 number:3 pages:0 http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 2 1992 3 0 |
| allfieldsSound |
10.1046/j.1525-1438.1992.02030141.x doi (DE-627)NLEJ239411528 DE-627 ger DE-627 rakwb Mogensen, O. verfasserin aut Nuclear volume and prognosis in ovarian cancer Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA Blackwell Scientific Publications 1992 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| morphometry Sørensen, F.B. verfasserin aut Bichel, P. verfasserin aut Jakobsen, A. oth In International journal of gynecological cancer Oxford [u.a.] : Wiley-Blackwell, 1991 2(1992), 3, Seite 0 Online-Ressource (DE-627)NLEJ243926197 (DE-600)2009072-9 1525-1438 nnns volume:2 year:1992 number:3 pages:0 http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 2 1992 3 0 |
| source |
In International journal of gynecological cancer 2(1992), 3, Seite 0 volume:2 year:1992 number:3 pages:0 |
| sourceStr |
In International journal of gynecological cancer 2(1992), 3, Seite 0 volume:2 year:1992 number:3 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
morphometry |
| isfreeaccess_bool |
false |
| container_title |
International journal of gynecological cancer |
| authorswithroles_txt_mv |
Mogensen, O. @@aut@@ Sørensen, F.B. @@aut@@ Bichel, P. @@aut@@ Jakobsen, A. @@oth@@ |
| publishDateDaySort_date |
1992-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243926197 |
| id |
NLEJ239411528 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ239411528</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506180143.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120426s1992 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j.1525-1438.1992.02030141.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ239411528</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mogensen, O.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nuclear volume and prognosis in ovarian cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA</subfield><subfield code="b">Blackwell Scientific Publications</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2002</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2002||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">morphometry</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sørensen, F.B.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bichel, P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jakobsen, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of gynecological cancer</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1991</subfield><subfield code="g">2(1992), 3, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243926197</subfield><subfield code="w">(DE-600)2009072-9</subfield><subfield code="x">1525-1438</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:1992</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">1992</subfield><subfield code="e">3</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Mogensen, O. |
| spellingShingle |
Mogensen, O. misc morphometry Nuclear volume and prognosis in ovarian cancer |
| authorStr |
Mogensen, O. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243926197 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1525-1438 |
| topic_title |
Nuclear volume and prognosis in ovarian cancer morphometry |
| publisher |
Blackwell Scientific Publications |
| publisherStr |
Blackwell Scientific Publications |
| topic |
misc morphometry |
| topic_unstemmed |
misc morphometry |
| topic_browse |
misc morphometry |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a j aj |
| hierarchy_parent_title |
International journal of gynecological cancer |
| hierarchy_parent_id |
NLEJ243926197 |
| hierarchy_top_title |
International journal of gynecological cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243926197 (DE-600)2009072-9 |
| title |
Nuclear volume and prognosis in ovarian cancer |
| ctrlnum |
(DE-627)NLEJ239411528 |
| title_full |
Nuclear volume and prognosis in ovarian cancer |
| author_sort |
Mogensen, O. |
| journal |
International journal of gynecological cancer |
| journalStr |
International journal of gynecological cancer |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1992 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Mogensen, O. Sørensen, F.B. Bichel, P. |
| container_volume |
2 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Mogensen, O. |
| doi_str_mv |
10.1046/j.1525-1438.1992.02030141.x |
| author2-role |
verfasserin |
| title_sort |
nuclear volume and prognosis in ovarian cancer |
| title_auth |
Nuclear volume and prognosis in ovarian cancer |
| abstract |
The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. |
| abstractGer |
The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. |
| abstract_unstemmed |
The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
3 |
| title_short |
Nuclear volume and prognosis in ovarian cancer |
| url |
http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x |
| remote_bool |
true |
| author2 |
Sørensen, F.B. Bichel, P. Jakobsen, A. |
| author2Str |
Sørensen, F.B. Bichel, P. Jakobsen, A. |
| ppnlink |
NLEJ243926197 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1046/j.1525-1438.1992.02030141.x |
| up_date |
2024-07-06T07:25:05.189Z |
| _version_ |
1803813603446358016 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ239411528</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506180143.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120426s1992 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j.1525-1438.1992.02030141.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ239411528</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mogensen, O.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nuclear volume and prognosis in ovarian cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Three Cambridge Center, Siute 208, Cambridge, MA 02142, USA</subfield><subfield code="b">Blackwell Scientific Publications</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prognostic value of the volume-weighted mean nuclear volume (MNV) was investigated retrospectively in 100 ovarian cancer patients with FIGO-stage IB–II (n = 51) and stage III–IV (n = 49) serous tumors. No association was demonstrated between the MNV and the survival or between the MNV and two of five additional parameters: age and amount of residual tumor. However, both in stage IB–II and stage III–IV carcinomas, the MNV increased significantly with increasing tumor grade and DNA-index. Furthermore, FIGO-stage IB–II patients had significantly smaller nuclei than patients with stage III–IV disease.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2002</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2002||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">morphometry</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sørensen, F.B.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bichel, P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jakobsen, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of gynecological cancer</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1991</subfield><subfield code="g">2(1992), 3, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243926197</subfield><subfield code="w">(DE-600)2009072-9</subfield><subfield code="x">1525-1438</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:1992</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j.1525-1438.1992.02030141.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">1992</subfield><subfield code="e">3</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.3977594 |